Michael has made over 8 trades of the Immunomedics stock since 2016, according to the Form 4 filled with the SEC. Most recently Michael exercised 2,500 units of IMMU stock worth $219,650 on 28 July 2017.
The largest trade Michael's ever made was selling 22,052 units of Immunomedics stock on 10 November 2016 worth over $2,669,174. On average, Michael trades about 3,491 units every 12 days since 2016. As of 28 July 2017 Michael still owns at least 3,488 units of Immunomedics stock.
You can see the complete history of Michael Pehl stock trades at the bottom of the page.
Michael's mailing address filed with the SEC is C/O CELGENE CORPORATION, 86 MORRIS AVENUE, SUMMIT, NJ, 07901.
Over the last 21 years, insiders at Immunomedics have traded over $5,318,095 worth of Immunomedics stock and bought 12,330,539 units worth $195,802,181 . The most active insiders traders include Capital Advisors Llc Aghaza..., David M Goldenberg und Cynthia L Goldenberg. On average, Immunomedics executives and independent directors trade stock every 105 days with the average trade being worth of $27,159,459. The most recent stock trade was executed by Barbara Gayle Duncan on 14 September 2020, trading 2,500 units of IMMU stock currently worth $42,400.
Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.
Immunomedics executives and other stock owners filed with the SEC include: